Esther Merki

1.4k total citations
10 papers, 1.1k citations indexed

About

Esther Merki is a scholar working on Surgery, Immunology and Biochemistry. According to data from OpenAlex, Esther Merki has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Immunology and 4 papers in Biochemistry. Recurrent topics in Esther Merki's work include Atherosclerosis and Cardiovascular Diseases (4 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Esther Merki is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (4 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Esther Merki collaborates with scholars based in United States, Italy and France. Esther Merki's co-authors include Sotirios Tsimikas, Joseph L. Witztum, Elizabeth R. Miller, Kenneth R. Chien, M. John Chapman, Sohvi Hörkkö, Christoph J. Binder, Min‐Jeong Shin, Alexina Orsoni and Asheesh K. Dewan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Esther Merki

10 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther Merki United States 10 531 479 288 241 157 10 1.1k
Kristina Skålén Sweden 7 304 0.6× 294 0.6× 388 1.3× 172 0.7× 181 1.2× 9 932
Tom Björnheden Sweden 13 303 0.6× 280 0.6× 275 1.0× 156 0.6× 163 1.0× 23 925
Belinda A. Di Bartolo Australia 19 326 0.6× 478 1.0× 283 1.0× 178 0.7× 171 1.1× 50 1.1k
Joseph C. Obunike United States 17 307 0.6× 390 0.8× 125 0.4× 352 1.5× 111 0.7× 19 1.1k
Panagiotis Fotakis United States 13 388 0.7× 413 0.9× 383 1.3× 109 0.5× 137 0.9× 18 981
Sandra Abramowicz United States 16 578 1.1× 682 1.4× 843 2.9× 172 0.7× 326 2.1× 19 1.8k
Jeanny Ohan France 6 199 0.4× 414 0.9× 416 1.4× 163 0.7× 146 0.9× 10 1.0k
Atsuyuki Nakata Japan 11 246 0.5× 430 0.9× 280 1.0× 97 0.4× 120 0.8× 14 808
S I Skarlatos United States 12 326 0.6× 207 0.4× 174 0.6× 186 0.8× 60 0.4× 18 671
Jan Willem N. Akkerman Netherlands 18 227 0.4× 254 0.5× 95 0.3× 280 1.2× 84 0.5× 29 1.2k

Countries citing papers authored by Esther Merki

Since Specialization
Citations

This map shows the geographic impact of Esther Merki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Merki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Merki more than expected).

Fields of papers citing papers by Esther Merki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Merki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Merki. The network helps show where Esther Merki may publish in the future.

Co-authorship network of co-authors of Esther Merki

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Merki. A scholar is included among the top collaborators of Esther Merki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Merki. Esther Merki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Eberle, Claudia, Esther Merki, Tomoya Yamashita, et al.. (2012). Maternal Immunization Affects In Utero Programming of Insulin Resistance and Type 2 Diabetes. PLoS ONE. 7(9). e45361–e45361. 21 indexed citations
2.
Merki, Esther, Mark J. Graham, Adam Taleb, et al.. (2011). Antisense Oligonucleotide Lowers Plasma Levels of Apolipoprotein (a) and Lipoprotein (a) in Transgenic Mice. Journal of the American College of Cardiology. 57(15). 1611–1621. 105 indexed citations
3.
Tsimikas, Sotirios, Atsushi Miyanohara, Karsten Hartvigsen, et al.. (2011). Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression. Journal of the American College of Cardiology. 58(16). 1715–1727. 91 indexed citations
4.
Bergmark, Claes, Asheesh K. Dewan, Alexina Orsoni, et al.. (2008). A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. Journal of Lipid Research. 49(10). 2230–2239. 300 indexed citations
6.
Choi, Seung‐Hyuk, et al.. (2007). Emerging approaches for imaging vulnerable plaques in patients. Current Opinion in Biotechnology. 18(1). 73–82. 10 indexed citations
7.
Bossola, Maurizio, Luigi Tazza, Esther Merki, et al.. (2007). Oxidized Low-Density Lipoprotein Biomarkers in Patients with End-Stage Renal Failure: Acute Effects of Hemodialysis. Blood Purification. 25(5-6). 457–465. 11 indexed citations
8.
Merki, Esther, et al.. (2007). Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.. PubMed. 55(6). 821–37. 59 indexed citations
9.
Merki, Esther, Mónica Zamora, Ángel Raya, et al.. (2005). Epicardial retinoid X receptor α is required for myocardial growth and coronary artery formation. Proceedings of the National Academy of Sciences. 102(51). 18455–18460. 279 indexed citations
10.
Jiang, Xiaobing, Bibha Choudhary, Esther Merki, et al.. (2002). Normal fate and altered function of the cardiac neural crest cell lineage in retinoic acid receptor mutant embryos. Mechanisms of Development. 117(1-2). 115–122. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026